Mats Stridsberg

<i>N</i> -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease

Stefan James, Bertil Lindahl, Agneta Siegbahn et al. · Circulation · 2003 · 581 citations

Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center

Eva Tiensuu Janson, Lars Holmberg, Mats Stridsberg et al. · Annals of Oncology · 1997 · 458 citations

Prognostic Factors, Surgical Oncology, Tumoral Pathology +8

Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

Roelf Valkema, Marion de Jong, Willem H. Bakker et al. · Seminars in Nuclear Medicine · 2002 · 430 citations

Medicine, Radionuclide Therapy, Peptide Library +8

Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus

E. Schvarcz, M.K. Palmer, Jan Åman et al. · Gastroenterology · 1997 · 417 citations

Obesity, Metabolic Syndrome, Physiology +10

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation

Tomas Jernberg, Mats Stridsberg, Per Venge et al. · Journal of the American College of Cardiology · 2002 · 342 citations

St-segment Elevation, Early Risk Stratification, Cardiovascular Disease +5